Company Filing History:
Years Active: 2023-2025
Title: Marta Szabat: Innovator in Antibody Research
Introduction
Marta Szabat is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of antibody research, particularly in the development of innovative therapies targeting human PAR-2.
Latest Patents
Marta Szabat holds 2 patents related to Anti-PAR-2 antibodies and methods of use thereof. These patents provide antibodies and antigen-binding fragments that specifically bind to human PAR-2. The disclosed antibodies block the interaction between a PAR-2 activating ligand and the extracellular domain of PAR-2. Furthermore, these antibodies can be utilized to treat various diseases associated with increased expression of PAR-2, including airway diseases, skin diseases, cancer, orofacial granulomatosis, inflammatory conditions, and pain.
Career Highlights
Marta Szabat is currently employed at Cephalon, Inc., where she continues her research and development efforts in the field of biotechnology. Her work focuses on creating effective treatments that can improve patient outcomes.
Collaborations
Marta has collaborated with notable colleagues, including Anna Mikaela Bracken and Adam Clarke, who contribute to her innovative research endeavors.
Conclusion
Marta Szabat's work in antibody research exemplifies the impact of innovation in the medical field. Her patents and ongoing research hold promise for advancing therapeutic options for various diseases.